Skip to search formSkip to main contentSkip to account menu

prostaglandin-inositol cyclic phosphate

Known as: cPIP, prostaglandyl-inositol cyclic phosphate, prostaglandylinositol cyclic phosphate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Inositol PhosphatesProstaglandins E

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Canadian Pandemic Influenza Preparedness: Antiviral strategy
  • B. Henry
  • Canada communicable disease report = Releve des…
  • 2019
  • Corpus ID: 59591249
Antiviral medications are the only influenza-specific pharmaceutical intervention that can be used to mitigate the impact of a… 
2018
2018
Canadian Pandemic Influenza Preparedness: Health sector planning guidance.
  • B. Henry
  • Canada communicable disease report = Releve des…
  • 2018
  • Corpus ID: 21733595
Pandemic preparedness requires a multifaceted approach with collaboration from all levels of government. The Canadian Pandemic… 
2017
2017
Antiallodynic Effects of Bee Venom in an Animal Model of Complex Regional Pain Syndrome Type 1 (CRPS-I)
Neuropathic pain in a chronic post-ischaemic pain (CPIP) model mimics the symptoms of complex regional pain syndrome type I (CRPS… 
2010
2010
Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major
Introduction Thalassaemic osteopathy is a multifactorial disorder and limited information exists about bone accrual and bone… 
2008
2008
THEORY OF SPIN-TRANSFER TORQUE IN THE CURRENT-IN-PLANE GEOMETRIES
Two alternative current-induced switching geometries, in which the current flows parallel to the magnet/nonmagnet interface, are… 
2006
2006
Use of in Vitro Critical Inhibitory Concentration, a Novel Approach to Predict in Vivo Synergistic Bactericidal Effect of Combined Amikacin and Piperacillin Against Pseudomonas aeruginosa in a…
PurposeThis study was undertaken to explore the use of in vitro critical inhibitory concentration (CIC) as a surrogate marker… 
1997
1997
Insulin resistance, a result of reduced synthesis of prostaglandylinositol cyclic phosphate, a mediator of insulin action?
Abstract Reduced ability or failure to stimulate cyclic adenosinemonophosphate (AMP) synthesis on a second addition of hormone 30… 
1994
1994
Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanisms of insulin action
Glucose tolerance tests in rats showed that after indomethacin treatment plasma insulin levels rose five-fold higher than in… 
1991
1991
Influence of endothelin on cardiovascular function, oxygen free radicals, and blood chemistry.
1987
1987
Prostaglandylinositol cyclic phosphate, an antagonist to cyclic AMP.
The existence of a low molecular weight intracellular regulator has been demonstrated. It is composed of PGE, myoinositol, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)